|1.||Shieh, Wun-Ju: 1 article (03/2013)|
|2.||Denison, Amy M: 1 article (03/2013)|
|3.||Bhatnagar, Julu: 1 article (03/2013)|
|4.||Zaki, Sherif R: 1 article (03/2013)|
|5.||Patel, Mitesh: 1 article (03/2013)|
|6.||Jones, Tara: 1 article (03/2013)|
|7.||Paddock, Christopher D: 1 article (03/2013)|
|8.||Rollin, Dominique C: 1 article (03/2013)|
|9.||Drew, Clifton: 1 article (03/2013)|
|10.||Blau, Dianna M: 1 article (03/2013)|
09/01/1997 - "Antisense probes directed against only exon 1 or 4 blocked hyperphagia at agonist doses of 0.5 and 1.0 microg; this pattern was identical to that observed for mu-mediated analgesia. "
09/01/1997 - "The present study examined whether central administration of antisense probes directed against each of the four exons of the MOR-1 clone or a missense control altered hyperphagia elicited by the mu agonist DAMGO across a range of doses. "
09/01/1997 - "The effective antisense probes failed to reduce hyperphagia at a higher (5 microg) agonist dose, a result consistent with limitations in down-regulation of receptor proteins by antisense. "
05/15/1998 - "Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia."
09/01/1997 - "The selective actions of antisense probes directed against different exons of the MOR-1 clone in reducing hyperphagia induced by DAMGO suggest that multiple splice variants of the MOR-1 clone exist and raise the possibility of further opioid receptor subclassifications."
01/01/2012 - "In situ hybridization allowed visualization of the regional expression of miR-143 and miR-145 in tumor samples, and antisense probes were used investigate in vitro phenotypic changes seen with knockdown in their expression. "
01/01/2011 - "We also identified 101 and 71 antisense probes displaying a high level of expression specifically in normal and cancer tissues respectively. "
06/01/2005 - "To further elucidate its role in steroidogenic tissues, mouse Leydig tumor cells (mLTC-1) were transfected with BRE antisense probes. "
02/01/2001 - "In situ hybridization with antisense probes designed on the basis of the sequence of the folate receptor was performed with frozen sections from 61 patients (33 epithelial and 28 mixed or sarcomatoid tumors) with malignant pleural mesothelioma. "
08/01/2012 - "Magnetic resonance tumor targeting imaging using gadolinium labeled human telomerase reverse transcriptase antisense probes."
03/01/2008 - "Distension had no effects on proliferation or necrosis but protected the cells from apoptosis, knocking-down PBEF with antisense probes abrogated this protective effect. "
01/01/1993 - "To determine if mononuclear cells (MNC) infiltrating various types of human solid tumours express genes for cytokines, in situ hybridisation with 35S-labelled cDNA antisense probes for interleukin 2 (IL2), interferon gamma (IFN-gamma), tumour necrosis factor alpha (TNF-alpha), interleukin 1-beta (IL1-beta), transforming growth factor beta (TGF-beta) and interleukin 2-receptors (IL2R) was performed. "
03/01/1994 - "Using radiolabelled Sulphur-35 antisense probes, viral genomic sequences were found in all three cases, but signal intensity was greatest in cases 1 and 2 with fulminant hepatitis, and was minimal in the third case of resolving hepatitis biopsied 2 months after acute illness. "
09/01/1992 - "The specificity of the hybridization signal was confirmed by neutralization with "cold" (i.e., unlabeled) probes and by absence of hybridization with non-A hepatitis and reverse antisense probes. "
|1.||Messenger RNA (mRNA)
|2.||Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)
|3.||Telomerase (Telomerase Reverse Transcriptase)
|4.||Opioid Receptors (Opioid Receptor)
|8.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|9.||(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamide